Compounded medication disclosures: Among the strongest in the category - Omzo's footer, Terms, and site disclosures all explicitly state compounded medications are not FDA-approved, not reviewed by FDA, and not equivalent to branded products
The magnitude of weight reduction, which approaches surgically achieved outcomes in some patient populations, has established Semaglutide as the primary research compound for investigating the neurobiological and metabolic mechanisms of pharmacological weight loss through central GLP-1R appetite circuit engagement
If you have questions about semaglutide GLP-1 injections or would like to discuss your options with a specialist, contact us today at Boca Medical Care or book online to schedule an appointment
The trial was conducted in accordance with the Declaration of Helsinki and Good Clinical Practice guidelines
Practical Monitoring And Management When Starting Semaglutide Baseline assessment: record weight, blood pressure, resting heart rate, ECG if there is a cardiac history, A1c if diabetic, renal function, and a medication review
For patients without insurance coverage for brand-name GLP-1 medications, compounded semaglutide provides access to the same molecule at a fraction of the cost